Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Hosted on MSN
6mon
康哲药业与Incyte宣布就口服JAK1抑制剂Povorcitinib在中国及东南亚订立合作和许可协议
Povorcitinib为Incyte的一种选择性口服JAK1抑制剂,正评估用于治疗非节段型白癜风、化脓性汗腺炎(HS)、结节性痒疹(PN)、哮喘和慢性自发性荨麻疹 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
‘New evidence’ emerges
How to help Milton victims
Ethel Kennedy dies at 96
T-shirt appeal to SCOTUS
Benefits set to rise
Suffers outage across US
Announces retirement
US warns of solar storm
Files suit against accuser
Inflation likely cooled again
Sex trafficking trial set
Jobless claims surge
Walz on Electoral College
Meat, poultry items recalled
Top colleges hit with lawsuit
Nobel Prize in literature
Increases heart attack risk?
To settle FTC charges
Tesla robotaxi launch
AZ Senate debate takeaways
GSK to settle 80K lawsuits
Judge tosses New York law
Idaho murder trial delayed
$273M Helene relief bill
Rare comet in October
Faces $3B in penalties
Ex-AR deputy sentenced
Feedback